Open Access

Impairment of NADH dehydrogenase and regulation of anaerobic metabolism by the small RNA RyhB and NadE for improved biohydrogen production in Enterobacter aerogenes

Biotechnology for Biofuels201710:248

Received: 17 July 2017

Accepted: 19 October 2017

Published: 30 October 2017



Enterobacter aerogenes is a facultative anaerobe and is one of the most widely studied bacterial strains because of its ability to use a variety of substrates, to produce hydrogen at a high rate, and its high growth rate during dark fermentation. However, the rate of hydrogen production has not been optimized. In this present study, three strategies to improve hydrogen production in E. aerogenes, namely the disruption of nuoCDE, overexpression of the small RNA RyhB and of NadE to regulate global anaerobic metabolism, and the redistribution of metabolic flux. The goal of this study was to clarify the effect of nuoCDE, RyhB, and NadE on hydrogen production and how the perturbation of NADH influences the yield of hydrogen gas from E. aerogenes.


NADH dehydrogenase activity was impaired by knocking out nuoCD or nuoCDE in E. aerogenes IAM1183 using the CRISPR-Cas9 system to explore the consequent effect on hydrogen production. The hydrogen yields from IAM1183-CD(∆nuoC/∆nuoD) and IAM1183-CDE (∆nuoC/∆nuoD/∆nuoE) increased, respectively, by 24.5 and 45.6% in batch culture (100 mL serum bottles). The hydrogen produced via the NADH pathway increased significantly in IAM1183-CDE, suggesting that nuoE plays an important role in regulating NADH concentration in E. aerogenes. Batch-cultivating experiments showed that by the overexpression of NadE (N), the hydrogen yields of IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N increased 1.06-, 1.35-, and 1.55-folds, respectively, compared with IAM1183. Particularly worth mentioning is that the strain IAM118-CDE/N reached 2.28 mol in H2 yield, per mole of glucose consumed. IAN1183/R, IAM1183-CD/R, and IAM1183-CDE/R showed increasing H2 yields in batch culture. Metabolic flux analysis indicated that increased expression of RyhB led to a significant shift in metabolic patterns. We further investigated IAM1183-CDE/N, which had the best hydrogen-producing traits, as a potential candidate for industry applications using a 5-L fermenter; hydrogen production reached up to 1.95 times greater than that measured for IAM1183.


Knockout of nuoCD or nuoCDE and the overexpression of nadE in E. aerogenes resulted in a redistribution of metabolic flux and improved the hydrogen yield. Overexpression of RyhB had an significant change on the hydrogen production via NADH pathway. A combination of strategies would be a novel approach for developing a more economic and efficient bioprocess for hydrogen production in E. aerogenes. Finally, the latest CRISPR-Cas9 technology was successful for editing genes in E. aerogenes to develop our engineered strain for hydrogen production.


Enterobacter aerogenes BiohydrogenNADH dehydrogenaseCRISPR-Cas9Small RNA RyhB


The ongoing rapid increase in world energy demand is mostly accommodated by conventional fossil fuels, e.g., petroleum, natural gas, and coal. Indeed, fossil fuels account for approximately 80% of world energy consumption [1, 2]. However, fossil fuels are a finite and nonrenewable energy resource and have had a serious, negative influence on the environment owing to the consequent emission of greenhouse gases, e.g., COx, NOx, and SOx. In response to this dual problem (i.e., depletion and pollution), scientists have become committed to exploring clean fuels that could substitute for fossil fuels [3, 4]. Among the potential clean fuels, hydrogen gas (H2), which produces only water when burned, is considered a clean, carbonless, and ideal alternative energy carrier because of its high conversion efficiency, recyclability, and environmentally friendly attributes [2, 3]. At present, however, hydrogen production is still highly dependent on fossil fuels. Therefore, new approaches for biohydrogen production, such as dark fermentation, photofermentation, and biophotolysis, have been widely investigated because the process of biohydrogen production could be environmentally sound [2, 5]. In particular, dark fermentative biohydrogen production from biomass also holds promise for developing new technologies suitable for industrial use [2, 5, 6].

Enterobacter aerogenes also called Klebsiella aerogenes, a facultative anaerobe, carries out fermentative hydrogen production similar to Escherichia coli and has a high H2 evolution rate; moreover, E. aerogenes grows rapidly during dark fermentation [6, 7]. This enterobacterium can produce H2 using a large range of carbon sources such as agriculture waste, industrial organic wastewater, or in combination with sewage [811], and E. aerogenes is regarded as an ideal strain for large-scale biohydrogen production. Therefore, it is necessary to delineate and understand the metabolic networks of hydrogen production from E. aerogenes.

Two metabolic pathways for producing hydrogen pertain to E. aerogenes [12, 13]. One is the formate pathway, which is based on the decomposition of formate mediated by the formate hydrogen lyase (FHL) system (Fig. 1) [13, 14]. The maximum yield of hydrogen by E. aerogenes through the formate pathway is 2 mol H2/mol glucose on account of the stoichiometry of the intracellular reactions. In our previous study, we knocked out the gene hycA, which encodes the formate hydrogenlyase repressor protein, and we also deleted the small subunit hybO of uptake hydrogenase [13]. It has been suggested that the hydrogen yield through the formate pathway can be enhanced by genetic manipulation of the FHL system. The other pathway is the NADH pathway (Fig. 1) [15], which can be regulated by altering the intracellular redox state, by external addition of NADH or NAD+, by blocking any pathway that would compete for NADH use, or by changing the NADH:NAD+ ratio during the production of hydrogen (Fig. 1) [12, 15, 16].
Fig. 1

Diagram of primary anaerobic metabolic pathways for bacterial hydrogen production. Shown are three putative strategies to enhance hydrogen yield as outlined in this study. The diagram was adapted from references [8], [17], and [18]

A substantial body of recent work has shown that small RNAs play an important role in regulating metabolism in bacteria and eukaryotes [17, 19]. RyhB, a small noncoding RNA, negatively regulates gene expression by base pairing with mRNAs to trigger their degradation via RNase E and RNase III [20]. RyhB is associated with various important cellular functions, including TCA cycle activity, resistance to oxidative stress, and iron homeostasis in many bacteria, such as E. coli and Klebsiella pneumoniae [17, 21, 22]. In E. coli, hycA and hybO are downregulated by RyhB under anaerobic conditions [23], suggesting that RyhB might influence the metabolic regulation of hydrogen production in E. aerogenes. Moreover, RyhB overexpression in E. coli conferred a sevenfold increase in succinate production, whereas no citrate was detected, and in acetate accumulated, while revealing the comprehensive effect of RyhB on glucose central metabolism [23]. Although the metabolic relevance of RyhB has been demonstrated in different species, the relationship between RyhB and hydrogen production capacity in E. aerogenes has not been studied.

Apart from the chemical reduction of various molecules to yield hydrogen molecules, the common metabolic cofactor NAD(H) is an indispensable participant in intracellular oxidation–reduction reactions in microbes [24, 25]. Cofactor engineering—an important branch of metabolic engineering—is accomplished mainly by changing the intracellular forms and levels of cofactors to manipulate metabolic fluxes for a particular metabolite or metabolic network [2527]. In essence, the flow of electrons, H+, NADH-shuttled H+, or energy translates into the production of hydrogen or participates in hydrogen metabolism in anaerobic fermentation (Fig. 1). Therefore, it is also important to know how to regulate the intracellular redox state of NADH/NAD+ pools to promote hydrogen production.

In this study, we adopted three strategies (Fig. 1) to improve hydrogen production in the wild-type E. aerogenes strain IAM1183. The genes nuoC, nuoD, and nuoE, which belong to the NADH dehydrogenase cluster, were knocked out in IAM1183 via the CRISPR-Cas9 gene-editing approach [28, 29] to create the double mutant IAM1183-CD (∆nuoC/∆nuoD) and triple mutant IAM1183-CDE (∆nuoC/∆nuoD/∆nuoE). To regulate anaerobic metabolism by the small RNA RyhB [21, 23] in IAM1183 in order to increase hydrogen production, RyhB was overexpressed in each of IAM1183, IAM1183-CD, and IAM1183-CDE. Moreover, nadE, which encodes nicotinic acid phosphoribosyl transferase (NAD synthetase) [18, 26, 30] from K. pneumonia, was cloned and heterologously expressed in IAM1183 and its mutant strains to modulate the intracellular NAD(H)/NAD+ pool to promote hydrogen production during anaerobic fermentation. To quantify how RyhB or/and NadE regulate anaerobic metabolism in IAM1183 and its mutants, a metabolic network model was constructed to facilitate the calculation of changes in metabolic flux distributions in mutants. The activities of three key enzymes in NADH-consuming pathways were also measured to understand the redistribution of the intracellular reducing power in all mutants. Among the mutants, the strain that exhibited the greatest hydrogen production was determined to be a preferred candidate for industrial bioproduction of hydrogen and was further investigated with respect to its potential to generate hydrogen in a fermenter. These results reveal the effect of nuoCDE, RyhB, and NadE on hydrogen production and how the modulation of intracellular NADH concentration influences the H2 yield from E. aerogenes.


Strains, plasmids, and materials

Table 1 lists the bacterial strains and plasmids used in this study. E. aerogenes IAM1183 was received as gift from the Green Industry Biotechnology Lab of Tsinghua University. E. coli DH5α and E. coli JM109 as host strains for genetic manipulation were purchased from TaKaRa Biotechnology (Dalian, China). Kits for genomic DNA purification, plasmid DNA purification, and DNA gel extraction were purchased from GenScript (USA). The Gibson assembly master mix kit, all restriction enzymes, DNA polymerase, and DNA-modifying enzymes were obtained from New England Biolabs (Beverly, MA, USA). Yeast extract and tryptone were acquired from Thermo Fisher Biochemicals (Beijing). Unless specifically indicated otherwise, all other chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Table 1

Strains and plasmids used in this study

Strain or plasmid

Genotype and relevant characteristics

Source or literature



Wild type

IAM (Tokyo, Japan)


Carrying plasmid pET-28a-nadE

This study


Carrying plasmid pKK102-ryhB-cm

This study


Carrying plasmid pET-28a-nadE and pKK102-ryhB-cm

This study



This study


nuoC/∆nuoD, carrying plasmid pET-28a-nadE

This study


nuoC/∆nuoD, carrying plasmid pKK102-ryhB-cm

This study


nuoC/∆nuoD, carrying plasmid pET-28a-nadE and pKK102-ryhB-cm

This study



This study


nuoC/∆nuoD/∆nuoE, carrying plasmid pET-28a-nadE

This study


nuoC/∆nuoD/∆nuoE, carrying plasmid pKK102-ryhB-cm

This study


nuoC/∆nuoD/∆nuoE, carrying plasmid pET-28a-nadE and pKK102-ryhB-cm

This study

 E. coli DH5α

F-, φ 80dlacZ ΔM15, Δ (lacZYA -argF) U169, deoR, recA1, endA1, hsdR17 (rK-, mK +), phoA, supE44, λ-, thi -1, gyrA96, relA1


 E. coli JM109

recA1, endA1, gyrA96, thi-1, hsdR17 (rk-mk +), e14-(mcrA-) supE44, relA1, Δ(lac-proAB)/F’[traD36, proAB+, lacIq, lacZ ΔM15]


 K. pneumoniae nov. sp

Wild type

This study



repA101(Ts) kan Pcas-cas9 ParaB-Red lacIq Ptrc-sgRNA-pMB1



pMB1 aadA sgRNA-cat



pMB1 aadA sgRNA-nuoN20

This study


N-His, N-Thrombin, N-T7, C-His, Kanr



Cm r , with multiple coning sites


 pMD18-T Vector

TA Cloning vector, Amp r



Amp r , derived from pMD18-T inserted nadE

This study


nadE, Kan r derived from pET-28a

This study


RyhB, Amp r



RyhB, Cm r derived pKK102-ryhB

This study

Culture medium and cultivation

Luria–Bertani broth containing 10 g L−1 tryptone, 5 g L−1 yeast extract, and 10 g L−1 NaCl was used to culture cells for genetic engineering and culture maintenance. Enterobacter aerogenes IAM1183, its mutants, and E. coli as host for genetic manipulation were grown in Luria–Bertani medium at 37 °C or 30 °C, supplemented with ampicillin (100 µg mL−1), kanamycin (25 or 50 µg mL−1), spectinomycin (50 µg mL−1), or chloramphenicol (25 µg mL−1), as required. Glucose medium containing 15 g L−1 glucose, 5 g L−1 tryptone, 14 g L−1 K2HPO4, 6 g L−1 KH2PO4, 2 g L−1 (NH4)2SO4, and 0.2 g L−1 MgSO4·7H2O 0 was used for hydrogen production, metabolic flux analysis, and bioreactor experiments.

Genetic manipulation

Table 2 lists detailed information for the primers used. Standard molecular genetics techniques were employed [32]. Genomic DNA from E. aerogenes IAM1183 was prepared as described [32] or per the kit manual supplied by the manufacturer. Plasmid DNA was purified using the QIAprep Spin Miniprep kit. The DNA was extracted from gel pieces using the GenScript DNA gel extraction kit. Amplification was carried out using a PCR apparatus from Bio-Rad (Hercules, CA, USA) with a final volume of 50 µL containing 5 µL of 10× PCR reaction buffer, 10 mM of each dNTP, 30–60 ng DNA template, 10 pmol each of the appropriate primers, and 0.5 U each of Taq polymerase and Pfu DNA polymerase (New England Biolabs). DNA sequencing was performed by Life Technologies (Shanghai Invitrogen, China).
Table 2

Primers used in the experiments


Oligonucleotide sequence (from 5′ to 3′)

PCR fragment




Upstream-homologous arm of nuoB

This study



This study



Downstream-homologous arm of nuoE

This study



This study



Upstream-homologous arm of nuoB

This study



This study



Downstream-homologous arm of nuoF

This study



This study




This study



This study



nadE ORF fragment

This study



This study



Chol ORF fragment

This study



This study

Relevant restriction enzyme sites are underlined and in italics

Based on the CRISPR-Cas9 gene-editing procedure [9, 28], the linear pTargetF-cat carrying nuoN20 was amplified from pTargetF-cat using primers F-nuoCD and R-nuoCD, then the linear pTargetF-cat carrying nuoN20 was self-assembled using the Gibson assembly method [31], yielding plasmid pTargetF-nuoN20. The linear upstream-homologous arm (nuoB) fragment and downstream-homologous arm (nuoE) fragment were amplified from the IAM1183 genome using the primers F-CDuh and R-CDuh as well as F-CDdh and R-CDdh. The donor linear DNA segment was constructed using the obtained purified products of the nuoB fragment and nuoE fragment by overlap extension using PCR. Plasmid pCas9 was electroporated into IAM1183 competent cells using the Bio-Rad Micro-Pulser Electroporator at 1800 V, and l-arabinose (10 mM final concentration) was added to the culture to induce λ-Red recombinase expression. For electroporation, 50 µL IAM1183 competent cells harboring pCas9 was mixed with 100 ng pTargetF-nuoN20 plasmid DNA and 400 ng donor DNA in a 2-mm Gene Pulser cuvette (Bio-Rad). The positive mutants were preliminarily screened by colony PCR. The standard method of nuoC/D/E gene knockout was the same as the above protocol, and the same pTargetF-nuoN20 was used to knock out nuoC/D/E. The linear upstream-homologous arm (nuoB) and downstream-homologous arm (nuoF) were amplified from the IAM1183 genome using primers F-CDEuh and R-CDEuh as well as F-CDEdh and R-CDEdh. Figures 1 and 2 illustrate the process by which nuoC/D/E loci were deleted. IAM1183 mutants with a disrupted nuoCD or nuoCDE, named IAM1183-CD or IAM1183-CDE, respectively, were further verified via sequencing by Life Technologies.
Fig. 2

Schematic diagram showing the ∆nuoCD and ∆nuoCDE mutants constructed using the CRISPR-Cas9 method

Overexpressions of ryhB and NadE

The plasmid pKK102-ryhB-cm was derived from plasmid pKK102-ryhB with ampicillin resistance to overexpress RyhB in E. aerogenes. First, the chloramphenicol cassette was amplified from pSTV28 plasmid DNA using primers F-p102-Chol and R-p102-Chol. The PCR fragment was double digested using restriction enzymes, spAlI and HindIII. The purified fragments containing the chloramphenicol cassette were inserted into pKK102-ryhB that had been digested with spAlI and HindIII to replace the ampicillin cassette to create pKK102-ryhB-cm. Plasmid pKK102-ryhB-cm was first transformed into E. coli DH5α or E. coli JM109, and positive colonies were screened on Luria–Bertani agar plate containing chloramphenicol (25 µg mL−1). Then, the purified pKK102-ryhB-cm was electrotransformed into IAM1183, IAM1183-CD, and IAM1183-CDE to generate IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R, respectively. When necessary, 0.6 g L−1 l-arabinose was added to induce RyhB expression.The RyhB expression in IAM1183/R was analyzed by northern blot (see Additional file 1: Figure S2).

Plasmid pET-28a-nadE, which was used to heterologously express NadE in E. aerogenes, was constructed via the following steps. The nadE open reading frame was amplified from the chromosome of K. pneumoniae nov. sp using primers F-nadE and R-nadE. The PCR product was inserted into pMD18-T and further confirmed by sequencing. The EcoRI and HindIII double-digested restriction fragments from pMD18-T-nadE were harvested and inserted into pET-28a that had been digested with the same restriction enzymes to create the expression plasmid pET-28a-nadE, which was first transformed into E. coli DH5α or E. coli JM109 for cultivation with 25 mg L−1 kanamycin. Then, the purified pET-28a-nadE plasmid DNA was electroporated into IAM1183, IAM1183-CD, and IAM1183-CDE to generate IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N, respectively. NadE overexpression was induced by the addition of 0.1 mM (final concentration) isopropylthio-galactoside.The NadE expression in IAM1183/N was checked by SDS-PAGE (see Additional file 1: Figure S1).

Assays for enzyme activities

All enzyme activities were measured under anaerobic conditions, and the reaction systems were prepared in an anaerobic chamber (Hengyue YQX- I, China) [33]. Bacterial cells were harvested by centrifugation for 10 min at 12,000 rpm at 4 °C after anaerobic cultivation for 8 h, and the pellet was resuspended in 100 mM potassium phosphate (pH 7.0). Cell-free extracts were prepared by ultrasonication (Ultrasonicator, FS30H, Fischer Scientific, Pittsburgh, PA) on ice. This approach allows enzyme activities to be measured by monitoring the decrease in absorbance of NADH (ε 340 = 6.3 mM−1 cm−1) via a spectrophotometer (Antpedia, UV-721G, China). Lactate dehydrogenase (LDH; EC activity was determined by measuring the decrease in NADH absorbance via a reaction system containing 1 mL imidazole–HCl (pH 6.7), 50 μL of 10 mM NADH, 1.5 mL of 0.5 mM sodium pyruvate, and 0.5 mL cell-free extract. Alcohol dehydrogenase (ADH; EC activity and 2,3-butanediol dehydrogenase (BDDH; EC activity were measured in a manner similar to that of LDH, except that 1.5 mL of 0.5 mM sodium pyruvate was substituted with 1.5 mL of 0.5 mM acetaldehyde and 1.5 mL of 10 mM acetoin, respectively.

Anaerobic serum-bottle batch cultivation for hydrogen production

All strains were cultured using 100-mL serum bottles with top caps and PTFE/silicone rubber septa in an anaerobic environment. Each bottle included 30 mL of fermentation medium. The air in the bottle and the small amount of oxygen in the fermentation medium were purged with aseptic nitrogen gas for 10 min to ensure anaerobic growth. The serum bottles were cultivated at 37 °C and 200 rpm for 20 h. The gas produced after 20 h of fermentation was passed through 5 M sodium hydroxide (1000-mL blue reagent bottle containing 500 mL 5 M sodium hydroxide solution) to clear any carbon dioxide.

Fermentation for hydrogen production

Fermentation experiments were performed at 37 °C with agitation at 250 rpm in a 5-L fermenter (Biostat A, Sartorius, Germany) containing 3 L medium without a pH control. Aseptic nitrogen was sparged for 90 min to purge residual air from the fermenter to ensure an anaerobic environment. The fermenter was then inoculated with an overnight seed broth at an inoculum size of 1.7% (v/v) and cultivated at 37 °C for 40 h. Carbon dioxide was absorbed via 5 M sodium hydroxide, and hydrogen production was measured using a wet-gas meter (Colom BSD0.5, China). Cell density and pH were monitored continuously. Samples were taken every 2 h. Concentrations of metabolites were determined using a high-performance liquid chromatography (HPLC) system (Shimadzu 10A, Japan).

Analysis of H2 and metabolites

Cell density was measured at 600 nm (OD600) with the UV-721G spectrophotometer. Dry cell weight was subsequently calculated as: dry cell weight (mg mL−1) = 0.132 × OD600 for E. aerogenes [8]. The total volume of gas produced in the anaerobic serum bottle was measured via displacing pure water within an inverted cylinder, and the total volume of hydrogen produced via the 5-L fermenter was measured using a wet-gas meter.

Components of the gas included ethanol and 2,3-butanediol, which were quantified using a gas chromatographic apparaus (Shimadzu GC-2010 Plus) equipped with a Parapak Q column and a thermal conductivity detector, with He as the carrier gas. The working temperature of the detector was 40 °C and that of the column was 200 °C.

A 10 mL sample drawn from the chemostat cultures was centrifuged at 12,000 rpm for 15 min at 4 °C, and the supernatant was collected for analysis of residual glucose and metabolites. The concentration of each of acetate, formate, lactate, citric acid, acetoin, succinate, and alcohols in the culture medium was determined using an HPLC system (Shimadzu LC-20A). The system was equipped with a C-18 column (Shimadzu PREP-ODS(H) KIT) and a refractive index detector (Shimadzu RID-10A). A 0.2% aqueous phosphoric acid solution was used as the mobile phase. The column temperature was 33 °C, and the flow rate was 0.8 mL min−1. The retention times for succinate, lactate, formate, acetate, 2,3-butanediol, and ethanol were 9.747, 3.884, 4.350, 5.760, 6.426, 8.346, and 3.290 min, respectively.

Results and discussion

Disruption of nuoCDE with the CRISPR-Cas9 gene-editing system

The CRISPR-Cas9-based precise gene-editing system [28, 29] was employed to knockout nuoC, nuoD, and nuoE (the NADH dehydrogenase subunits in IAM1183) to systematically examine the effect of NADH dehydrogenase level on hydrogen production and carbon flux redistribution under anaerobic conditions (Figures 1 and 2). The standard gene-editing protocols for disruption of the nuoCDE genes are summarized in Fig. 2 [21]. Positive mutants were identified by colony PCR using primers F-CDuh/R-CDdh or F-CDEuh/R-CDEdh. Approximately 1–2% of colonies had a positive signal, implying that one or two colonies were presumably correct. The positive colonies were sent to Sangon Biotech for sequencing, and the results suggested that nuoCD and nuoCDE were indeed knocked out of the IAM1183 genome, and that the CRISPR-Cas9 system could be used as a powerful genetic manipulation tool to precisely edit genes in E. aerogenes. The positive transformants in which nuoCD and nuoCDE were deleted were named IAM1183-CD and IAM1183-CDE, respectively.

Characterization of all mutants and measurement of hydrogen production

All strains were cultivated to measure hydrogen production in 100-mL serum bottles with 30 mL glucose medium under anaerobic conditions [13]. The wild-type IAM1183 served as the control. According to the growth curves for all strains (Fig. 3), after 24 h of culture, the cell density was greater for both strains ∆nuoCD and ∆nuoCDE compared with IAM1183 (Fig. 3a). The exponential phase of each of IAM1183-CD and IAM1183-CDE was estimated by recording the time when the cell density reached 95 and 75% of maximum, respectively (Fig. 3a). Compared with the 8-h exponential phase of IAM1183, the exponential phases of mutants IAM1183-CD and IAM1183-CDE were prolonged by ~ 2 and ~ 4 h, respectively (Fig. 3a). The density of each of IAM1183-CD/R and IAM1183-CDE/R was somewhat greater than the respective IAM1183 and IAM1183/R at the end of the 24-h cultivation. The final OD600 value for IAM1183 did not differ from that of IAM1183/R (Fig. 3b). Based on OD600, the final densities of IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N were greater than that of IAM1183 by 1.11-, 1.26-, and 1.40-fold, respectively. Moreover, compared with the 8-h plateau phase of IAM1183, the plateau phase of the three mutants was delayed by ~ 2–4 h (Fig. 3c). These results demonstrated that expression nadE in IAM1183 and in ∆nuoCD or ∆nuoCDE had a positive effect on fermentation. The trends of growth characteristics of all ∆nuoCD and ∆nuoCDE mutants were similar (Fig. 3), implying that RyhB level did not affect cell growth in these strains.
Fig. 3

Comparison of cell growth (in terms of OD600) for IAM1183 and its mutants. a Growth curves for IAM1183-CD and IAM1183-CDE. b Growth curves for IAM1183/R, IAM1183-CD/R, and IAM1183CDE/R. c Growth curves for IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N

During the 20-h batch cultivation, the pH of the culture medium of each mutant except IAM1183/N decreased at a slower rate compared with IAM1183 (Fig. 4). However, the final pH of the medium differed by only ~ 0.33 among the strains (Fig. 4). Comparison of pH for IAM1183 and its mutants, and the pH values of accurate cultivating time at 4-h and final 20-h are summarized as shown in Table 3. The pH values for the mutants (range, 5.45 ± 0.07 to 5.93 ± 0.04) except for IAM1183/N (5.13 ± 0.07) during exponential growth (0–8 h) were higher than for IAM1183 (5.31 ± 0.12). These results were particularly relevant for potential application of these mutants in large-scale H2 production (Fig. 4 and Table 3) [13, 15]. This apparent elevation in the medium pH for the mutants might be one of the reasons why the final OD600 values for all mutants were somewhat higher than that for strain IAM1183 (Fig. 3). After 20 h of cultivation, the final values of pH (range, 4.39 ± 0.09 to 4.72 ± 0.09) for all three mutants were close to that of IAM1183 (4.65 ± 0.08), i.e., within the margin of xperimental error (Fig. 4 and Table 3). These observations suggest that disruption of NADH metabolism did not have a negative effect on the pH of medium.
Fig. 4

Comparison of pH of the medium over time for IAM1183 and its mutants during the 20-h batch cultivation. a The pH curves for IAM1183CD and IAM1183CD. b The pH curves for IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R. c The pH curves for IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N

Table 3

Comparison of the optimal pH for growth between IAM1183 and its mutants at the midpoint of exponential growth and after 20 h of batch cultivation












Exponential phase (4-h)

5.31 ± 0.12

5.13 ± 0.07

5.61 ± 0.1

5.93 ± 0.04

5.51 ± 0.16

5.45 ± 0.07

5.85 ± 0.19

5.79 ± 0.11

5.82 ± 0.15

Stationary phase (20-h)

4.65 ± 0.08

4.7 ± 0.06

4.47 ± 0.14

4.72 ± 0.09

4.56 ± 0.13

4.53 ± 0.12

4.54 ± 0.17

4.39 ± 0.09

4.67 ± 0.08

As shown in Fig. 5, each mutant produced significantly more hydrogen than IAM1183. The hydrogen production of per mole of glucose consumed by mutants IAM1183-CD and IAM1183-CDE was 26.2 and 47.6% greater compared with the wild-type stain (Fig. 5a and Table 4). Moreover, for IAM1183-CDE compared with IAM1183, hydrogen produced via the NADH pathway was significantly elevated (2.31-fold, Fig. 5d) and that via the formate pathway significantly reduced (1.36-fold, Fig. 5a). A previous study reported that nuoE encodes the NADH dehydrogenase module bearing the NADH-binding and FMN-binding sites and four Fe-S clusters [34], implying that nuoE may play major role in the NADH pathway in E. aerogenes. These results suggest that components encoded by nouC, nouD, and nouE have an apparent effect on hydrogen production in E. aerogenes.
Fig. 5

The hydrogen production from glucose compared by IAM1183 among all strains in serum bottle batch assays (n = 3). The yield of H2 generated through the formate pathway can be calculated by the following equation V h  = V e  + V a  − V f , where V h is the amount of hydrogen produced through the formate pathway, V e is the amount of ethanol, V a is the amount of acetate, and V f is the amount of formate. a Hydrogen evolved from IAM1183-CD and IAM1183-CDE. b Hydrogen evolved from IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R. c Hydrogen evolved from IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N. d Special illustration of hydrogen evolved via the NADH pathway

Table 4

Analysis of consumed substrate and the production of anaerobic metabolites after 20 h of cultivation in a serum bottle for wild-type IAM1183 and mutants (n = 3)

End product











Glucose consumed (mM)

57.42 ± 1.38

59.27 ± 0.69

60.62 ± 0.85

70.02 ± 0.66

68.13 ± 0.94

74.05 ± 0.43

69.02 ± 0.77

69.28 ± 0.49

71.09 ± 0.39

Residual sugar (mM)

4.66 ± 0.25

4.33 ± 0.12

4.09 ± 0.15

2,4 ± 0.12

2.74 ± 0.17

1.67 ± 0.08

2.58 ± 0.14

2.53 ± 0.09

2.2 ± 0.07

2,3-Butanediol (mM)

9.35 ± 1.56

11.86 ± 0.91

11.53 ± 0.78

11.73 ± 1.37

24.75 ± 0.42

13.79 ± 1.09

8.26 ± 0.17

11.96 ± 0.78

10.69 ± 0.26

Lactate (mM)

23.62 ± 0.46

44.15 ± 0.99

31.54 ± 0.96

18.78 ± 1.03

25.33 ± 0.81

22.31 ± 0.66

32.14 ± 0.29

36.61 ± 0.45

38.21 ± 0.36

Acetate (mM)

17.27 ± 0.32

10.36 ± 0.39

20.31 ± 0.65

27.96 ± 0.69

23.17 ± 0.55

30.52 ± 1.26

17.16 ± 0.31

15.27 ± 0.13

16.01 ± 0.63

Formate (mM)

2.24 ± 0.17

3.92 ± 0.77

2.83 ± 0.98

6.19 ± 0.76

5.98 ± 0.47

8.28 ± 1.62

3.67 ± 0.34

2.92 ± 0.19

1.63 ± 0.27


1.86 ± 0.08

1.01 ± 0.11

2.31 ± 0.19

3.22 ± 0.17

3.02 ± 0.12

3.59 ± 0.36

3.79 ± 0.48

3.02 ± 0.12

3.86 ± 0.23

Ethanol (mM)

31.93 ± 1.2

13.85 ± 2.02

38.09 ± 0.98

38.69 ± 1.16

14.47 ± 1.32

40.87 ± 0.72

25.14 ± 0.26

23.49 ± 1.19

29.96 ± 0.77

Citric acid (mM)

1.68 ± 0.25

1.52 ± 0.49

1.43 ± 0.33

1.69 ± 0.37

1.51 ± 0.72

1.65 ± 0.96

1.57 ± 0.67

1.62 ± 0.22

1.64 ± 0.93

Acetoin (mM)

25.71 ± 1.11

19.21 ± 0.58

27.32 ± 0.64

20.99 ± 0.84

20.13 ± 0.74

25.02 ± 0.17

23.19 ± 0.29

26.81 ± 0.44

25.62 ± 0.51

H2 yield (mol/mol glucose)

1.47 ± 0.06

1.52 ± 0.13

1.56 ± 0.17

1.83 ± 0.09

1.67 ± 0.41

1.99 ± 0.22

2.14 ± 0.69

2.08 ± 0.12

2.28 ± 0.12

However, overexpression of RyhB in IAM1183/R caused only a modest increase in hydrogen production (3.7%) compared with IAM1183. For IAM1183/R, hydrogen produced via the formate pathway decreased by 60% compared with IAM1183 (Fig. 5b), implying that RyhB represses the formate pathway in E. aerogenes. As the previous study reported that the expression of hycA gene, the operon of formate lyase, was decreasing [17], which maybe explain the above result. Besides, in comparison with IAM1183-CD, the production of H2 decreased by 7.2% of IAM1183-CD/R, and the strain IAM1183-CDE/R had a slight decrease on H2 production compared with IAM1183-CDE (Table 3). RyhB suppresses the expression of at least 44 genes under anaerobic conditions, including Fe-binding proteins and factors involved in the TCA cycle, and this fact may explain these differences in H2 production [17]. These unusual results may be due to a blockade of the ethanol biosynthesis pathway under anaerobic conditions, in which NADH is consumed more rapidly compared with other NADH-consuming pathways.

Cofactor engineering is accomplished mainly by changing the intracellular forms and levels of cofactors to manipulate metabolic fluxes for a particular metabolite or metabolic network [25, 26]. Expression of NadE regulates the NADH/NAD+ pool and reconstitutes the metabolic flux to promote hydrogen production. In our present study, compared with IAM1183, overexpression of NAD synthetase led to a significant increase in hydrogen yields for strains IAM1183/N (+ 6%), IAM1183-CD/N (+ 35%), and IAM1183-CDE/N (+ 55%) (Table 4 and Fig. 5c). Moreover, 15% more hydrogen was produced by the formate pathway in IAM1183/N compared with IAM1183 (Fig. 5c). These results did correspond with previous reports, in which supplementation of the culture medium with NADH led to a decrease in hydrogen production via the NADH pathway and an increase in production via the formate pathway [13, 15, 16]. Interestingly, however,, 17.5% more hydrogen was produced by the NADH pathway in IAM1183-CD/N compared with IAM1183-CD. The result could be due to the impairment of NADH dehydrogenase by knockout nuoC/D, which could influence the intracellular redox state of NADH. We also found that hydrogen production from IAM1183-CDE/N was 1.07-fold greater compared with IAM1183-CDE and that the concentrations of acetate and formate were 6.7 and 55.6% lower, respectively (Table 4), indicating that NADH provided via supplementation not only is used by the NADH pathway to produce hydrogen but also affects the intracellular metabolism of E. aerogenes. The results of these experiments demonstrate that hydrogen production can be enhanced by increasing the total intracellular pool of NAD(H).

It was very meaningful for evaluating the potential to regulate NADH for biohydrogen production. The hydrogen produced via the NADH pathway of all strains is compared in Fig. 5d. For the NADH pathway, IAM1183-CD and IAM1183-CDE produced 1.45-fold and 2.31-fold more hydrogen than IAM1183 (Fig. 5d). Apparently, the nuoCDE knockout substantially increased the conversion of NADH to H2 via the NADH pathway, implying that nuoE normally downregulates the hydrogen production via the NADH pathway in E. aerogenes. Moreover, the hydrogen produced via the NADH pathway of IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R was also increased by 1.63-, 1.23-, and 1.01-fold compared with IAM1183, IAM1183-CD, and IAM1183-CDE, respectively (Fig. 5d), which demonstrates that RyhB can enhance hydrogen production via the NADH pathway. However, the NadE expressed in IAM1183 and its mutants seemed to play a lesser role in converting NADH to H2 via the NADH pathway. The hydrogen produced via the NADH pathway of IAM1183/N was 4.5% lower compared with IAM1183, and for strains IAM1183-CD/N and IAM1183-CDE/N there was no significant difference in H2 yield via the NADH pathway (Fig. 5d), which is consistent with previous results [35]. These results suggest that disruption of nuoCDE could be an effective approach for promoting the conversion of NADH to hydrogen and overexpression of RyhB had a profound influence on the way of formation in hydrogen production.

Analysis of the metabolite flux

Table 4 reports the final concentrations of the major excreted metabolites of all strains. The yields of 2,3-butanediol, acetate, and ethanol for IAM1183-CD were greater than for IAM1183, whereas the yield of lactate was lower, indicating that the lactate pathway was repressed by the double knockout of nuoC and nuoD. Moreover, IAM1183-CDE had significantly elevated concentrations of lactate (36%) and formate (64%) compared with IAM1183, whereas concentration of each of acetate (1%) and 2,3-butanediol (12%) was significantly lower. The fact that all these metabolites are produced through NADH-consuming pathways implies that nuoCD and nuoCDE mutants had altered intracellular NADH/NAD+ pools and underwent a redistribution of metabolic fluxes accordingly. Meanwhile, the relatively rapid growth of IAM1183-CD and IAM1183-CDE cells compared with IAM1183 indicated that the exponential growth phase was prolonged in these two mutants (Fig. 3a), which was presumably due to the decrease in the level of NADH dehydrogenase in these two mutants and the consequent reduction in energy conservation during exponential growth.

RyhB has a global cellular effect on glucose metabolism [23]. We thus analyzed the metabolic flux of IAM1183/R, IAM1183 CD/R, and IAM1183-CDE/R. Compared with IAM1183, IAM1183/R yielded a greater amount of each of 2,3-butanediol (+ 26%) and lactate (+ 86%) (Table 4), whereas the concentrations of other metabolic products were lower compared with IAM1183. These results suggest that RyhB alters the size of the intracellular pool of NADH or NAD+, thereby affecting H2 productivity. Compared with IAM1183, IAM1183-CD/R produced significantly greater concentrations of acetate (+ 34.2%), lactate (+ 7.2%), 2,3-butanediol (+ 165%), and formate (+167%) yet produced less ethanol (− 55%) (Table 4). A previous study suggested that NAD+ regeneration tended to be quicker in the presence of excess reducing equivalents [35], and the results of our experiments showed that IAM1183-CD/R had a significantly altered composition of the intracellular NADH/NAD+ pools when the concentration of NADH increased above the physiologically normal level. We also compared the metabolic landscape of strain IAM1183-CD/R with that of IAM1183-CD, noting that ethanol production in both strains was ~ 63% lower compared with the wild-type strain IAM1183 and that ADH activity in IAM1183 was 1.24, 1.1, and 1.03 times that measured in IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R, respectively. Moreover, the ethanol concentration of mutant IAM1183-CDE/R was 6.6% lower than that of IAM1183-CDE. These results indicate that RyhB represses ethanol biosynthesis. The anaerobic metabolic flux of one mole of glucose, as affected by RyhB, was further analyzed to reveal the effect on IAM1183. As shown in Fig. 6, overexpression of ryhB altered the synthesis of all metabolites in IAM1183. This demonstrates that ryhB could alter the expression of genes that control the redox state of anaerobic metabolism and thereby downregulate the production of the terminal electron acceptor, i.e., H+, for hydrogen evolution under anaerobic conditions.
Fig. 6

Metabolic distribution of IAM1183 upon overexpression of the small RNA RyhB and NadE after 20 h of cultivation (n = 3). The unit is mole. Redox state balance was calculated as the sum of the products with positive oxidation states and those with negative oxidation states per mole of consumed glucose (W IAM1183, R IAM1183-R, CD/R IAM1183-CD/R, IAM1183-CDE/R, N IAM1183-N, CD/N IAM1183-CD/N, and IAM1183-CDE/N)

Overexpression of NAD synthetase led to a significant change in the concentrations of fermentation-related metabolites in strain IAM1183-CD/N. Compared with IAM1183/CD, there were increases in 2,3-butanediol (17.6%), acetate (9.2%), ethanol (5.6%), formate (33.8%), and lactate (18.8%) (Table 4). However, the carbon flux was altered through repression of the acetate and formate production pathways in IAM1183-CDE/N compared with IAM1183-CDE. The production of each of acetate (71.2%), formate (133%), and 2,3-butanediol (33.9%) was significantly elevated in IAM1183/RN compared with IAM1183 (Table 4), indicating that theses mutations could substantially influence the production of acetate and formate.

The anaerobic metabolic distribution of one mole glucose from adjusting by NadE was also further analyzed to detect effect on IAM1183 in Fig. 6. As shown in Fig. 6, the overexpression of NadE caused different synthesis level of metabolites in IAM1183. It demonstrated that NadE could alter the genes that control the redox state of anaerobic metabolism and therefore promote the anaerobic reduction of terminal electron acceptor hydrogen proton(H+) for the hydrogen evolution under anaerobic conditions.

Detection of specific enzyme activities in mutants

To examine how disruption of nuoCDE, NadE, or RyhB affected the activities of key oxidoreductases involved in the anaerobic metabolism of all mutants, we compared three specific enzyme activities for which NADH is as cofactor (LDH, EC; ADH, EC; BDDH, EC among the mutant strains after cultivation for 8 h (mid-exponential phase). Compared with IAM1183, IAM1183-CD exhibited a 1.9-fold and a 1.5-fold decrease in LDH and BDDH activity, respectively, although ADH activity increased by ~ 40% (Fig. 7). The three mutants IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R exhibited a dramatic reduction in all three enzyme activities. A previous study reported that hyaA encoded small subunit of hydrogenase 1, which plays a vital role on hydrogenase 1, was downregulated upon RyhB overproduction under anaerobic conditions [21]. This may underlie the observed decrease in BDDH, LDH, and ADH activities in IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R.
Fig. 7

Comparison of enzyme activities between the wild-type strain and mutants (n = 3). a Alcohol dehydrogenase (EC, ADH). b Lactate dehydrogenase (EC, LDH). c 2,3-butanediol dehydrogenase (EC1.1.1.4, BD DH)

Hydrogen production by IAM1183-CDE/N in a fermenter

Among all mutants, IAM1183-CDE/N produced the most H2 (2.39 mol H2/mol glucose) during batch serum-bottle fermentation (Table 4), and so we used IAM1183-CDE/N for our pilot large-scale fermentation experiment. A scaled-up fermentation was thus carried out in 3-L glucose-containing medium in a 5-L fermenter. Compared with IAM1183, IAM1183-CDE/N exhibited a prolonged exponential phase (4 h longer) and had 1.3-fold increased cell density based on final OD600 after cultivation for 44 h (Fig. 8a). The final pH values of the medium for IAM1183-CDE/N and IAM1183 were 5.04 and 4.82 (Fig. 8b), respectively. These observations indicated that strain IAM1183-CDE/N produced less formate so that more hydrogen produced from formate pathway than IAM1183-CDE or that certain acidic metabolites might have been taken up by the IAM1183-CDE/N cells and utilized as substrates for anabolic processes (Table 5). We however, note that this difference in pH units, i.e., 0.22, is seemingly minor unless this aspect was repeatedly observed in several 5-L fermenter experiments. More glucose was consumed by IAM1183-CDE/N during fermentation, which resulted in a nearly twofold greater production of H2 compared with IAM1183 (Fig. 8c).
Fig. 8

Characterization of IAM1183-CDE/N in a 5-L fermenter. a Growth curves. b Change in pH. c H2 evolved during the cultivation between IAM1183-CDE/N and the wild-type strain

Table 5

Analysis of consumed substrate and anaerobic metabolites after 44 h of cultivation of IAM1183-CDE/N and wild-type IAM1183 in 5-L fermenter

End product



Change trend

Percent change (%)

Glucose consumption (%)




Residual sugar (g/L)




Hydrogen (H2) (L)




Succinate (mM)




Lactate (mM)




Acetate (mM)




Formate (mM)




Ethanol (mM)




Citric acid (mM)




Acetoin (mM)




2,3-Butanediol (mM)




After 44 h of culture in the fermenter, the final concentrations of the major excreted metabolites of IAM1183-CDE/N and IAM1183 were also accordingly measured and summarized in Table 5. As shown in Table 5, the final concentrations of lactate and 2,3-butanediol were greater for IAM1183-CDE/N than for IAM1183, whereas the concentrations of acetate and formate decreased; these results were similar to those obtained with the serum-bottle batch system. The mutants generated in this work can be used for further studies of the mechanism of hydrogen metabolism in E. aerogenes and for potential applications in biohydrogen production.


The present work demonstrates that the CRISPR-Cas9-mediated knockout of nuoCDE to downregulate NADH hydrogenase in E. aerogenes can significantly improve hydrogen yield using glucose as substrate. Moreover, the increasing range of H2 production via the NADH pathway was apparently greater than that via formate pathway. The most interesting result was that nuoE had a greater influence on E. aerogenes in terms of hydrogen metabolism. We also explored the significance of enhancing overall hydrogen production by ∆nuoCDE mutants and the influence on the formation of hydrogen production by overexpressing RyhB in E. aerogene. Metabolic flux analysis indicated that RyhB could block the alcohol pathway and thereby constitutes a competitive route for hydrogen production. Heterologous expression of the nadE gene from K. pneumonias in E. aerogenes and its ∆nuoCDE mutants led to a further increase in hydrogen production and metabolic flux redistribution. Therefore, the small RNA RyhB and NadE may play global regulatory roles in anaerobic metabolism for improved biohydrogen production. The volume of hydrogen produced by the mutant strain IAM1183-CDE/N in the fermenter was almost two times greater than that produced by the wild-type strain. Hence, IAM1183-CDE/N may be a promising candidate to further improve hydrogen production using genetic technologies. The findings reported herein also have the potential for further studies of the mechanism underlying hydrogen metabolism in E. aerogenes and for applications to biohydrogen production.



reduced nicotinamide adenine dinucleotide


nicotinamide adenine dikaryotic synthetase


nicotinamide adenine dikaryotic acid


clustered regularly interspaced short palindromic repeats/CRISPR-associated


lactate dehydrogenase


alcohol dehydrogenase


2,3-butanediol dehydrogenase


polytetra fluoroethylene


high-performance liquid chromatography


pondus hydrogenii


Authors’ contributions

HXZ, YL, and YW analyzed and interpreted the patient data regarding the hematological disease and the transplant. YW performed all the experiments and analyzed the results along with HXZ and YL. The manuscript was written by YW with contributions from all authors. All authors read and approved the final manuscript.


The authors gratefully thank Professor Qingsheng Qi of Shandong University and Professor Sheng Yang of Shanghai Institutes for Biological Sciences for kindly providing the pKK102 plasmid containing ryhB and the CRISPR-Cas9 System, respectively. The authors are grateful to the Wuxi Research Institute of Applied Technologies at Tsinghua University for technical support with the BatchPro software used for bioreactor monitoring and management.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.


This work was supported by grants from the National Natural Science Foundation of China (31601671), the Science Public Welfare Fund Projects of Zhejiang Province (2017C32050), and Talent Fund Projects of Zhejiang Sci-tech University (116129326 11513).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Zhejiang Province Key Laboratory of Plant Secondary Metabolism and Regulation, College of Life Sciences, Zhejiang Sci-Tech University
Key Lab of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University
Department of Chemical Engineering, Institute of Biochemical Engineering, Tsinghua University
College of Life Science, Shenyang Normal University


  1. Passos F, Uggetti E, Carrère H, Ferrer I. Pretreatment of microalgae to improve biogas production: a review. Bioresour Technol. 2014;172:403–12.View ArticleGoogle Scholar
  2. Azwar MY, Hussain MA, Abdul-Wahab AK. Development of biohydrogen production by photobiological, fermentation and electrochemical processes: a review. Renew Sust Energy Rev. 2014;31:158–73.View ArticleGoogle Scholar
  3. Khan MA, Ngo HH, Guo W, Liu Y, Zhang X, Guo J, Chang SW, Nguyen DD, Wang J. Biohydrogen production from anaerobic digestion and its potential as renewable energy. Renew Energy. 2017. doi:10.1016/j.renene.2017.04.029.Google Scholar
  4. Cha M, Chung D, Elkins JG, Guss AM, Westpheling J. Metabolic engineering of Caldicellulosiruptor bescii yields increased hydrogen production from lignocellulosic biomass. Biotechnol Biofuels. 2013;6:85.View ArticleGoogle Scholar
  5. Hallenbeck PC. Fundamentals of the fermentative production of hydrogen. Water Sci Technol. 2005;52:21.Google Scholar
  6. Sinha P, Pandey A. An evaluative report and challenges for fermentative biohydrogen production. Int J Hydrogen Energy. 2011;36:7460–78.View ArticleGoogle Scholar
  7. Rachman MA, Nakashimada Y, Kakizono T, Nishio N. Hydrogen production with high yield and high evolution rate by self-flocculated cells of Enterobacter aerogenes in a packed-bed reactor. Appl Microbiol Biotechnol. 1998;49:450–4.View ArticleGoogle Scholar
  8. Zhao H, Lu Y, Wang L, Zhang C, Yang C, Xing X. Disruption of lactate dehydrogenase and alcohol dehydrogenase for increased hydrogen production and its effect on metabolic flux in Enterobacter aerogenes. Bioresour Technol. 2015;194:99–107.View ArticleGoogle Scholar
  9. Lu Y, Lai Q, Zhang C, Zhao H, Ma K, Zhao X, Chen H, Liu D, Xing XH. Characteristics of hydrogen and methane production from cornstalks by an augmented two- or three-stage anaerobic fermentation process. Bioresour Technol. 2009;100:2889–95.View ArticleGoogle Scholar
  10. Ghimire A, Frunzo L, Pirozzi F, Trably E, Escudie R, Lens PNL, Esposito G. A review on dark fermentative biohydrogen production from organic biomass: process parameters and use of by-products. Appl Energy. 2015;144:73–95.View ArticleGoogle Scholar
  11. Boboescu IZ, Ilie M, Gherman VD, Mirel I, Pap B, Negrea A, Kondorosi É, Bíró T, Maróti G. Revealing the factors influencing a fermentative biohydrogen production process using industrial wastewater as fermentation substrate. Biotechnol Biofuels. 2014;7:139.View ArticleGoogle Scholar
  12. Tanisho S, Kamiya N, Wakao N. Hydrogen evolution of Enterobacter aerogenes depending on culture pH: mechanism of hydrogen evolution from NADH by means of membrane-bound hydrogenase. BBA Bioenergy. 1989;973:1–6.View ArticleGoogle Scholar
  13. Zhao H, Ma K, Lu Y, Zhang C, Wang L, Xing XH. Cloning and knockout of formate hydrogen lyase and H2-uptake hydrogenase genes in Enterobacter aerogenes for enhanced hydrogen production. Int J Hydrogen Energy. 2009;34:186–94.View ArticleGoogle Scholar
  14. McDowall JS, Murphy BJ, Haumann M, Palmer T, Armstrong FA, Sargent F. Bacterial formate hydrogenlyase complex. Proc Natl Acad Sci USA. 2014;111:E3948–56.View ArticleGoogle Scholar
  15. Zhang C, Ma K, Xing XH. Regulation of hydrogen production by Enterobacter aerogenes by external NADH and NAD+. Int J Hydrogen Energy. 2009;34:1226–32.View ArticleGoogle Scholar
  16. Lu Y, Zhao H, Zhang C, Lai Q, Wu X, Xing XH. Alteration of hydrogen metabolism of ldh-deleted Enterobacter aerogenes by overexpression of NAD (+)-dependent formate dehydrogenase. Appl Microbiol Biotechnol. 2010;86:255–62.View ArticleGoogle Scholar
  17. Beauchene NA, Myers KS, Chung D, Park DM, Weisnicht AM, Keleş S, Kiley PJ. Impact of anaerobiosis on expression of the iron-responsive Fur and RyhB regulons. mBio. 2015;6(6):e01947–15. doi:10.1128/mBio.01947-15.View ArticleGoogle Scholar
  18. Heuser F, Schroer K, Lütz S, Bringer-Meyer S, Sahm H. Enhancement of the NAD(P)(H) pool in Escherichia coli for biotransformation. Eng Life Sci. 2007;7:343–53.View ArticleGoogle Scholar
  19. Machner MP, Storz G. Infection biology: small RNA with a large impact. Nature. 2016;529:472–3.View ArticleGoogle Scholar
  20. Masse E, Escorcia FE, Gottesman S. Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli. Genes Dev. 2003;17:2374–83.View ArticleGoogle Scholar
  21. Masse E, Vanderpool CK, Gottesman S. Effect of RyhB small RNA on global iron use in Escherichia coli. J Bacteriol. 2005;187:6962–71.View ArticleGoogle Scholar
  22. Huang SH, Wang CK, Peng HL, Wu CC, Chen YT, Hong YM, Lin CT. Role of the small RNA RyhB in the Fur regulon in mediating the capsular polysaccharide biosynthesis and iron acquisition systems in Klebsiella pneumoniae. BMC Microbiol. 2012;12:148.View ArticleGoogle Scholar
  23. Kang Z, Wang X, Li Y, Wang Q, Qi Q. Small RNA RyhB as a potential tool used for metabolic engineering in Escherichia coli. Biotechnol Lett. 2012;34:527–31.View ArticleGoogle Scholar
  24. San KY, Bennett GN, Berrı́os-Rivera SJ, Vadali RV, Yang YT, Horton E, Rudolph FB, Sariyar B, Blackwood K. Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. Metab Eng. 2002;4:182–92.View ArticleGoogle Scholar
  25. Xu N, Ye C, Chen X, Liu J, Liu L. Genome-scale metabolic modelling common cofactors metabolism in microorganisms. J Biotechnol. 2017;251:1–13.View ArticleGoogle Scholar
  26. Liang L, Liu R, Wang G, Gou D, Ma J, Chen K, Jiang M, Wei P, Ouyang P. Regulation of NAD(H) pool and NADH/NAD + ratio by overexpression of nicotinic acid phosphoribosyltransferase for succinic acid production in Escherichia coli NZN111. Enzyme Microb Technol. 2012;51:286–93.View ArticleGoogle Scholar
  27. Ghosh D, Bisaillon A, Hallenbeck PC. Increasing the metabolic capacity of Escherichia coli for hydrogen production through heterologous expression of the Ralstonia eutropha SH operon. Biotechnol Biofuels. 2013;6:122.View ArticleGoogle Scholar
  28. Jiang Y, Chen B, Duan C, Sun B, Yang J, Yang S. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microb. 2015;81:2506–14.View ArticleGoogle Scholar
  29. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protocols. 2013;8:2281–308.View ArticleGoogle Scholar
  30. Jauch R, Humm A, Huber R, Wahl MC. Structures of Escherichia coli NAD synthetase with substrates and products reveal mechanistic rearrangements. J Biol Chem. 2005;280:15131–40.View ArticleGoogle Scholar
  31. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6:343–5.View ArticleGoogle Scholar
  32. Miller Jeffrey H. Experiments in molecular genetics. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1972.Google Scholar
  33. Ma K, Zhao H, Zhang C, Lu Y, Xing XH. Impairment of NADH dehydrogenase for increased hydrogen production and its effect on metabolic flux redistribution in wild strain and mutants of Enterobacter aerogenes. Int J Hydrogen Energy. 2012;37:15875–85.View ArticleGoogle Scholar
  34. Efremov RG, Baradaran R, Sazanov LA. The architecture of respiratory complex I. Nature. 2010;465:441–5.View ArticleGoogle Scholar
  35. Wang J, Yu W, Xu L, Wang S, Yan Y. Effects of increasing the NAD(H) pool on hydrogen production and metabolic flux distribution in Enterobacter aerogenes mutants. Int J Hydrogen Energy. 2013;38:13204–15.View ArticleGoogle Scholar


© The Author(s) 2017